Sutro Biopharma, Inc.
Institutional holders · 13F as of Dec 31, 2025
| Holder | Value | % of shares |
|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | $1.62M | 0.84% |
| TWO SIGMA INVESTMENTS, LP | $1.62M | 0.39% |
| Point72 Asset Management, L.P. | $2.07M | 1.08% |
| Opaleye Management Inc. | $2.21M | 1.15% |
| Eversept Partners, LP | $2.24M | 1.17% |
| Samsara BioCapital, LLC | $2.37M | 1.23% |
| Renaissance Technologies LLC | $2.44M | 0.59% |
| Vestal Point Capital, LP | $2.81M | 1.47% |
| Velan Capital Investment Management LP | $3.61M | 1.88% |
| GEODE CAPITAL MANAGEMENT, LLC | $4.27M | 1.03% |
| VANGUARD GROUP INC | $4.35M | 2.27% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4.98M | 1.21% |
| Millennium Management LLC | $5.24M | 1.27% |
| MARSHALL WACE, LLP | $5.55M | 1.34% |
| Kynam Capital Management, LP | $5.55M | 2.89% |
| Affinity Asset Advisors, LLC | $8.66M | 4.51% |
| Merck & Co., Inc. | $9.04M | 1.64% |
| STATE STREET CORPORATION | $10.16M | 1.85% |
| Balyasny Asset Management L.P. | $11.60M | 2.81% |
| RA Capital Management, L.P. | $17.82M | 4.31% |
| Perceptive Advisors LLC | $17.82M | 4.31% |
| ORBIMED ADVISORS LLC | $19.96M | 4.83% |
| BVF INC/IL | $31.18M | 7.55% |
| BlackRock, Inc. | $37.27M | 6.77% |